Company intelligence / Profile preview

Madison Scientific

Chicago, Illinois, United Statesmadisonscientific.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Madison Scientific is developing the SmartShunt Hydrocephalus Management System, an advanced electro-mechanical shunt designed to improve outcomes and reduce failure rates in patients with hydrocephalus. The system incorporates state-of-the-art technology and algorithms to enhance diagnostic capabilities. As of March 2025, the company has raised $7 million in seed funding to expand preclinical testing and prototype development. The SmartShunt is not yet approved for clinical use

Therapeutic areas: Neurology
Modalities: DeviceElectro-mechanical device (SmartShunt System)
Industry: Implantable Medical Devices

Drug pipeline

1 asset

SmartShunt System

Pre-clinical

Indications: Hydrocephalus

Partnerships

WARF VenturesIsthmus Project

Beyond the preview

Go deeper on Madison Scientific.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Madison Scientific.

Explore the full profile